domingo, 1 de junio de 2025

Combination treatment reduces risk of tumor progression in aggressive form of breast cancer, study shows Use of Gilead’s Trodelvy, Merck’s Keytruda together could change practice, experts say

https://www.statnews.com/2025/05/31/trodelvy-keytruda-breast-cancer-gilead-merck-results/

No hay comentarios:

Publicar un comentario